5TQG image
Deposition Date 2016-10-24
Release Date 2017-02-01
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5TQG
Title:
Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2-difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Factor VIIa (Heavy Chain)
Gene (Uniprot):F7
Chain IDs:A (auth: H)
Chain Length:254
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Factor VIIa (Light Chain)
Gene (Uniprot):F7
Chain IDs:B (auth: L)
Chain Length:55
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.
ACS Med Chem Lett 8 67 72 (2017)
PMID: 28105277 DOI: 10.1021/acsmedchemlett.6b00375

Abstact

Two novel series of meta-linked phenylglycine-based macrocyclic FVIIa inhibitors have been designed to improve the rodent metabolic stability and PK observed with the precursor para-linked phenylglycine macrocycles. Through iterative structure-based design and optimization, the TF/FVIIa Ki was improved to subnanomolar levels with good clotting activity, metabolic stability, and permeability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures